SAREPTA THERAPEUTICS, INC. Inventory, Work in Process, Gross
SAREPTA THERAPEUTICS, INC. (SRPT) had Inventory, Work in Process, Gross of $946.65 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2026-08-05
- 2026-06-30: Inventory, Work in Process, Gross $946.65M.
- 2026-03-31: Inventory, Work in Process, Gross $981.04M.
- 2025-12-31: Inventory, Work in Process, Gross $892.69M.
- 2025-09-30: Inventory, Work in Process, Gross $885.42M.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2026-06-30 | $946.65M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $981.04M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $892.69M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $885.42M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $802.87M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $762.23M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $610.69M 10-K · filed 2026-03-02 |
| 2023-12-31 | $318.46M 10-K · filed 2025-02-28 |
| 2022-12-31 | $269.19M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |